HQY's strong HSA growth, AI-driven efficiencies and raised fiscal 2027 outlook support momentum, though cybersecurity risks remain a concern.
HealthEquity's investment case is anchored in its demonstrated ability to translate slowing revenue growth into robust profitability, with operating margins expanding from 15.2% in 2025Q1 to 28.1% in 2027Q2.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth has decelerated from a peak of 23.1% in 2025Q2 to 7.6% in 2027Q2, yet gross margins have expanded dramatically from 56.2% to 73.5% over the same period, indicating strong operating leverage on the technology platform.
HealthEquity reported first-quarter revenue of US$354.64 million and net income of US$69.42 million, with a raised full-year fiscal 2027 earnings outlook.
HealthEquity offers more than an industry-leading Health Savings Account (HSA), providing comprehensive benefits solutions for employers.
Bullish theses from ValueInvestorsClub and Substack highlight optimism around HealthEquity's growth potential and market position.
Trailing total returns as of 11/19/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 27, 2026 | $1.24+4.2% vs $1.19 | $351M+0.4% vs $349M |
Q2 2026 May 28, 2026 | $1.24+11.7% vs $1.11 | $355M+0.7% vs $352M |
Q2 2026 Mar 17, 2026 | $0.95+6.7% vs $0.89 | $335M+0.7% vs $332M |
Q4 2025 Dec 3, 2025 | $1.01+10.7% vs $0.91 | $322M+0.5% vs $321M |
HQY's strong HSA growth, AI-driven efficiencies and raised fiscal 2027 outlook support momentum, though cybersecurity risks remain a concern.
DRAPER, Utah, Nov. 03, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced plans to release financial results for its third quarter of fiscal 2027, after the closing of regular stock market trading on Tuesday, December 1, 2026. Following the news release, HealthEquity management will host a conference call for investors on Tuesday, December 1, 2026, at 4:30 p.m. Eastern Time to review the Company's third quarter results.
Investors interested in Medical Services stocks are likely familiar with Bausch + Lomb (BLCO) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

Benchmark HQY against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for HealthEquity, Inc. (HQY)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $101.84 | $8.51B | 36.18 | 9.47% | 17.36% | 11.43% | — | |
| $181.62 | $6.19B | 15.53 | 1.24% | 14.05% | 32.33% | — | |
| $34.41 | $17.88B | 15.19 | 7.43% | 12.38% | 8.15% | 3.93% | |
| $18.30 | $1.35B | 6.82 | 18.52% | 43.79% | 15.84% | — | |
| $145.42 | $12.11B | 87.30 | 22.7% | 9.44% | 10.03% | — | |
| $177.50 | $9.5B | 34.13 | 11.04% | 15.39% | 24.03% | — |
HealthEquity, Inc. (HQY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
HealthEquity, Inc. (HQY) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 27, 2026·SEC
May 28, 2026·SEC
May 8, 2026·SEC
Get notified when HQY posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
HealthEquity, Inc. (HQY) stock FAQ — growth, dividends, profitability & financials explained
HealthEquity, Inc. (HQY) reported $1.36B in revenue over the trailing twelve months. Revenue was $1.31B in fiscal year 2026. That is 2750% more than the $46.1M of fiscal year 2013.
HealthEquity, Inc. (HQY) grew revenue by 7.3% over the trailing twelve months, compared with the twelve months before.
Yes. HealthEquity, Inc. (HQY) earned $236.5M in net income over the trailing twelve months (a 17.4% net margin).
HealthEquity, Inc. (HQY) had a return on equity (ROE) of 11.4% over the trailing twelve months. That is in line with the market's typical 10-15%.
HealthEquity, Inc. (HQY) generated $471.7M in free cash flow over the trailing twelve months.